Outcomes worse with secondary and therapy-related AML compared with de novo AMLAugust 24, 2015Leukemia, Myelodysplasia, Transplantation
The LAST Study: CML trial examines life after TKIsAugust 14, 2015Leukemia, Myelodysplasia, Transplantation
Febuxostat better than allopurinol for preventing tumor lysis syndromeAugust 10, 2015Patient & Survivor CareLeukemia, Myelodysplasia, Transplantation
Pretransplant support helps cancer patients sleep betterAugust 7, 2015Patient & Survivor CareLeukemia, Myelodysplasia, Transplantation
R-ISS identifies three survival patterns in multiple myelomaAugust 4, 2015Leukemia, Myelodysplasia, Transplantation
FDA approves carfilzomib for relapsed multiple myelomaJuly 24, 2015Leukemia, Myelodysplasia, Transplantation
Genetic mutation identifies favorable prognosis MDSJuly 23, 2015Leukemia, Myelodysplasia, Transplantation
EHA: High-risk APL curable with chemo-free comboJuly 18, 2015Leukemia, Myelodysplasia, Transplantation
CML patients die from comorbidities, not leukemiaJuly 17, 2015Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
P13K inhibitors TGR-1202, duvelisib found clinically active in CLLJune 26, 2015Leukemia, Myelodysplasia, TransplantationFollicular Lymphoma
Advanced age no barrier to continuous myeloma regimenJune 26, 2015Leukemia, Myelodysplasia, Transplantation
VIDEO: Ibrutinib should be therapy ‘backbone’ in relapsed CLLJune 19, 2015Leukemia, Myelodysplasia, Transplantation
Less intensive childhood cancer therapy reduces late toxicities, deathsJune 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPatient & Survivor Care
Dexrazoxane Tx did not affect overall survival in pediatric leukemia and lymphomaMay 26, 2015Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
